Substratos Cromogénicos

Os substratos cromogênicos são compostos que produzem uma mudança de cor visível quando são metabolizados por enzimas específicas. Esses substratos são amplamente utilizados em ensaios diagnósticos, pesquisa bioquímica e ensaios imunoenzimáticos (ELISA) para detectar e quantificar a atividade enzimática. A mudança de cor permite uma identificação visual fácil e rápida das reações enzimáticas, tornando os substratos cromogênicos ferramentas essenciais na análise laboratorial. Na CymitQuimica, oferecemos uma seleção diversificada de substratos cromogênicos de alta qualidade para apoiar suas aplicações de pesquisa e diagnóstico.

Ler mais

20
- 50
- 100
- 200

produtos por página. 790 produtos desta categoria.

Dados do produto	Pureza	Gama de preços	Estimativa de entrega
5-Bromo-4-chloro-3-indoxyl-α-D-galactopyranoside REF: 3D-B-7141CAS: 107021-38-5	Min. 99 Area-%	A consultar	Seg 13 Jan 25
Aldol® 455 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4689_P00CAS: 1318785-27-1	Min. 92.0 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, cyclohexylammonium salt monohydrate REF: 3D-B-7300CAS: 114162-64-0	Min. 99.0 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-β-D-fucopyranoside REF: 3D-B-7136CAS: 17016-46-5	Min. 99.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 515 caprylate hydrochloride REF: 3D-A-4781_P00CAS: 2484873-14-3	Min. 95 Area-%	A consultar	Seg 13 Jan 25
Aldol® 584 β-D-glucuronic acid, triethylammonium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4768_P00CAS: 2484873-11-0	Min. 95.0 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt, high grade REF: 3D-B-7500CAS: 6578-06-9	Min. 98.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 455 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4684_P00CAS: 1254797-99-3	Min. 93.0 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl thymidine-3'-phosphate, cyclohexylammonium salt REF: 3D-B-7680CAS: 341973-00-0	Min. 98 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside REF: 3D-B-7250CAS: 15548-60-4	Min. 98.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4691_P00CAS: 1254797-77-7	Min. 95.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4701_P00CAS: 1254798-26-9	Min. 95.0 Area-%	A consultar	Seg 13 Jan 25
6-Bromo-2-naphthyl-α-D-galactopyranoside REF: 3D-B-8925CAS: 25997-59-5	Min. 98 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside REF: 3D-B-7134CAS: 1301706-80-8	- - -	A consultar	Seg 13 Jan 25
Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4673_P00CAS: 2484872-46-8	Min. 95.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4715_P00CAS: 2484873-16-5	Of Solute (Hplc) 95.0 To 100.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4672_P00CAS: 1254798-15-6	Min. 95 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside REF: 3D-B-7044	Min. 99.0 Area-%	A consultar	Seg 13 Jan 25
Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4714_P00CAS: 2484873-15-4	Of Solute (Hplc) 98.0 To 100.0 Area-%	A consultar	Seg 13 Jan 25
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous REF: 3D-B-7398CAS: 129541-41-9	Min. 98.0 Area-%	A consultar	Seg 13 Jan 25

1g		A consultar
100mg		A consultar
250mg		A consultar
500mg		A consultar
2500mg		A consultar

1g		A consultar
50mg		A consultar
100mg		A consultar
250mg		A consultar
500mg		A consultar

Substratos Cromogénicos

5-Bromo-4-chloro-3-indoxyl-α-D-galactopyranoside

Ref: 3D-B-7141

Aldol® 455 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4689_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, cyclohexylammonium salt monohydrate

Ref: 3D-B-7300

5-Bromo-4-chloro-3-indoxyl-β-D-fucopyranoside

Ref: 3D-B-7136

Aldol® 515 caprylate hydrochloride

Ref: 3D-A-4781_P00

Aldol® 584 β-D-glucuronic acid, triethylammonium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4768_P00

5-Bromo-4-chloro-3-indoxyl phosphate, p-toluidine salt, high grade

Ref: 3D-B-7500

Aldol® 455 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4684_P00

5-Bromo-4-chloro-3-indoxyl thymidine-3'-phosphate, cyclohexylammonium salt

Ref: 3D-B-7680

5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside

Ref: 3D-B-7250

Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4691_P00

Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4701_P00

6-Bromo-2-naphthyl-α-D-galactopyranoside

Ref: 3D-B-8925

5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside

Ref: 3D-B-7134

Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4673_P00

Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4715_P00

Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4672_P00

5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside

Ref: 3D-B-7044

Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4714_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous

Ref: 3D-B-7398